セッション詳細
[WS(O)12]Innate Immunity 2: Innate immune cell
2024年12月3日(火) 15:25 〜 16:40
Room D
Organizers: Shinichiro Sawa (Medical Institute of Bioregulation, Kyushu University), Tsukasa Nabekura (Aichi Cancer Center, Research Institute)
[WS12-03-O/P]CD36 is an inhibitory CpG ODN/CXCL14 receptor that limits the tumor-suppressive activity
○Kosuke Tanegashima1, Manaka Hasebe1,2, Risa Saito1,3, Riku Takahashi1,3, Takahiko Hara1,2,3 (1.Stem cell project, Tokyo Metropolitan Institute of Medical Science, 2.Grad. Sch. of Tokyo Metropol. Univ., 3.Grad. Sch. of Tokyo Medical and Dental Univ.)
[WS12-05-O/P]Characterization of anti-asialo-GM1 monoclonal antibodies
○Ka He1, Tatsuji Kimura2, Kazuyoshi Takeda3, Yoshihiro Hayakawa1 (1.Institute of Natural Medicine, University of Toyama, 2.Diagnostic Division, Yamasa Corporation, 3.Laboratory of Cell Biology, Graduate School of Medicine, Juntendo University)
[WS12-08-O/P]PD-L1 expressing CD127+ ILC1s inhibit PD-1+ γδ T cells in the mesenteric adipose tissue to alleviate murine peritonitis
○Ritsu Nagata1,3, Yuichi Akama4, Pedro Goncalves5, Nicolas Serafini5, Tomoko Kageyama2, Manami Satoh1,3, Motomu Shimaoka4, Hiroshi Ohno1,3, Naoko Satoh-Takayama2,3 (1.Laboratory for Intestinal Ecosystem, Center for Integrative Medical Sciences RIKEN, 2.Precision Immune Regulation RIKEN ECL Research Unit, Center for Integrative Medical Sciences, RIKEN, 3.Graduate School of Medical Life Science, Yokohama City University, 4.Department of Molecular Pathobiology and Cell Adhesion Biology, Mie University Graduate School of Medicine, 5.Institut Pasteur, Université Paris Cité, Inserm U1223, Innate Immunity Unit)
[WS12-09-O/P]ILC1-Derived Amphiregulin Regulates Epithelial Turnover in Response to Mechanical Stress in the Skin
○Tetsuro Kobayashi1, Daisuke Asanuma2, Shigeyuki Namiki2, Kenzo Hirose2, Kazuyo Moro1,3,4 (1.Laboratory for Innate Immune Systems, RIKEN IMS, 2.Department of Pharmacology, Graduate School of Medicine, The University of Tokyo, 3.Laboratory for Innate Immune Systems, Graduate School of Medicine, Osaka University, 4.Laboratory for Innate Immune Systems, iFReC, Osaka University)
[WS12-11-O/P]Identification of a FURIN-Dependent ILC2 Regulatory Mechanism Not Mediated by the p38-GATA3 Pathway
○Takuya Yashiro1, Kazuyo Moro1,2,3 (1.Laboratory for innate immune systems, Graduate school of medicine, Osaka university, 2.Laboratory for Innate Immune Systems, RIKEN-IMS, 3.Laboratory for Innate Immune Systems, IFReC, Osaka University)
[WS12-15-O/P]Dietary antigens enhance ILC3s and regulate intestinal homeostasis
○Ayana Mori1,2, Shiho Nagata1,3, Tomoko Kageyama2, Naoko Tachibana3, Hiroshi Ohno3,4, Naoko Satoh-Takayama1,2 (1.Immunobiology Laboratory, Graduate School of Medical Life Science, Yokohama City University, Yokohama, Japan, 2.Precision Immune Regulation RIKEN ECL research Unit, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan, 3.Laboratory for Intestinal Ecosystem, RIKEN Center for Integrative Medical Sciences, Yokohama, Japan, 4.Laboratory for Immune Regulation, Graduate School of Medicine, Chiba University, Chiba, Japan)
[WS12-16-O/P]Development of a novel proliferation method of invariant Natural Killer T cells
○Kiwamu Motoyoshi, Takahiro Aoki, Mariko Takami, Shinichiro Motohashi (Department of Medical Immunology, Graduate school of medicine, Chiba University)